12/10/25 UPDATE: We are excited to share this GeneReviews letter supporting a part of our mission. Read the PDF here.

The myth of X-linked conditions not impacting women and girls ends here.

Misinformation about
X-linked conditions ends with Rare Rewritten.

Extensive medical research has shown, unequivocally, that women and girls frequently do develop physical symptoms associated with X-linked conditions.

Many resources, such as medical websites and textbooks, have been slow to catch up, leaving the symptoms of women and girls with X-linked conditions under-acknowledged, under-researched, and under-treated. Remember The Girls is working to change that with our Rare Rewritten campaign.

Remember The Girls is a non-profit organizing aiming to break the stigma facing females impacted by X-linked conditions by providing them with tools to seek support, engage with research, and access family planning options, as well as by advocating for increased attention of medical professionals to the physical, emotional, and reproductive needs of this community.

These are examples of online medical resources that do not accurately reflect what we know about X-linked conditions and how they impact females. This list is not comprehensive.

Here's what we're asking:

Ask #1

Describe the inheritance pattern as “X-linked” rather than using the terms “dominant” or “recessive” (the latter distinction many experts suggest is biologically inaccurate).

Ask #2

Avoid the term “carrier” in descriptions of X-linked inheritance—many females with X-linked conditions are symptomatic and not simply carriers.

Ask #3

Explain that the likelihood of symptoms in females varies from condition-to-condition and person-to-person due to various factors, one being random versus skewed X-inactivation.

We drafted a letter to rewrite these wrongs.

Remember The Girls developed a letter calling on organizations to correct inaccurate representations of X-linked inheritance and the impact of X-linked conditions on women and girls.

In the letter, we ask recipients to rewrite the wrongs in alignment with our three key ‘asks,’ supported by detailed, evidence-based explanations for each point.

Developed with guidance from our Medical Advisory Board, the letter is also backed by seven rare disease patient advocacy groups.

As part of our Rare Rewritten campaign, we created two versions of the letter to support each wave of outreach: Wave 1 targets organizations that publish medical websites, while Wave 2 is directed toward medical textbook editors.

 

A line art illustration of a child holding their parents' hands on a walk.

Wave 1: Medical Websites

We began by targeting organizations that publish medical websites, such as the NIH’s MedLinePlus. These resources are widely referenced by healthcare professionals, medical organizations, patients, and families seeking reliable health information. When these resources contain inaccurate or incomplete information about X-linked inheritance, they can reinforce misconceptions and contribute to gaps in diagnosis, care, and understanding. Ensuring this information accurately reflects how X-linked conditions affect both males and females is an important first step toward changing the narrative.

Wave 2: Medical Textbooks

For our second wave, we are turning our attention to medical textbook editors. Medical textbooks shape the foundational knowledge of current and future healthcare professionals, influencing how they recognize, diagnose, and treat patients. By correcting outdated information about X-linked inheritance, we hope to ensure the next generation of providers understands that X-linked conditions can, and often do, affect females, too. Addressing these gaps in medical education is essential to challenging long-standing misconceptions and improve recognition of X-linked conditions in women and girls.

These are the recipients of our letter.

Here are the five medical websites we have chosen to send our letters to. We chose these websites because of their credibility among patients and providers.

OMIM®

OMIM® (Online Mendelian Inheritance in Man)

Comprehensive database that catalogs human genes and genetic disorders.

omim.org

MAY 2026: We sent a follow-up including a letter of support from Margaret Adam, MD, Editor-in-Chief of GeneReviews

 

MedLine Plus

MedLine Plus

Online health information resource for patients and families, maintained by the U.S. National Library of Medicine, part of the National Institutes of Health (NIH).

https://medlineplus.gov/genetics/understanding/inheritance/inheritancepatterns/
https://medlineplus.gov/ency/article/002048.htm

https://medlineplus.gov/ency/article/002051.htm

JULY 2025 UPDATE: MedlinePlus responded that they will review our information on X-linked conditions, particularly how they impact females, and make any necessary updates.

APRIL 2026 UPDATE: We sent a follow-up including a letter of support from Margaret Adam, MD, Editor-in-Chief of GeneReviews

APRIL 2026 UPDATE: MedlinePlus indicated that they “have worked to prioritize updates to their X-linked condition pages” and “have made meaningful progress in revising their inheritance language.”

CHOP
Children’s Hospital of Pennsylvania (CHOP)

One of the most prestigious children’s hospitals in the world, its website provides resources for patients and families, clinicians, educators, and researchers.

https://www.chop.edu/conditions-diseases/x-linked-recessive-red-green-color-blindness-hemophilia

MAY 2026: We sent a follow-up including a letter of support from Margaret Adam, MD, Editor-in-Chief of GeneReviews

NHS England Genomics Education Programme

NHS England Genomics Education Programme

A national initiative in England designed to equip the current and future NHS workforce with the knowledge, skills, and confidence to integrate genomics into clinical care.

https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/x-linked-recessive-inheritance/

MAY 2026: We sent a follow-up including a letter of support from Margaret Adam, MD, Editor-in-Chief of GeneReviews

NIH National Cancer Institute

NIH National Cancer Institute

The U.S. government’s principal agency for cancer research and training, its website offers resources for patients & caregivers, researchers, and healthcare professionals.

https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/x-linked-recessive-inheritance
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/x-linked-dominant-inheritance

MAY 2026: We sent a follow-up including a letter of support from Margaret Adam, MD, Editor-in-Chief of GeneReviews

Help us spread the message.

A hand signing a paper with a pen.
Share the Mission

We developed a social media media kit for our partners to help spread awareness of Rare Rewritten and amplify our campaign message across their networks.

Join The Cause

We created a petition on Change.org to bring even more awareness to Rare Rewritten and to show the level of support for our message.

Sign up and get the latest on the Rare Rewritten campaign.

11 + 4 =

Rare Rewritten by Remember The Girls. All rights reserved.